MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Filanesib

CAS No. : 885060-09-3

MCE 國(guó)際站：Filanesib

產(chǎn)品活性：Filanesib (ARRY-520) 是一種選擇性的，非競(jìng)爭(zhēng)性的紡錘體驅(qū)動(dòng)蛋白 (KSP) 抑制劑，對(duì)人 KSP 作用的 IC₅₀ 值為 6 nM。Filanesib 在體外能通過(guò)誘導(dǎo)自噬 (apoptosis) 導(dǎo)致細(xì)胞死亡。Filanesib 具有高效的抗增生活性。

研究領(lǐng)域：Cell Cycle/DNA Damage  |  Cytoskeleton  |  Apoptosis

作用靶點(diǎn)：Kinesin  |  Apoptosis

In Vitro: Filanesib induces mitotic arrest in multiple cell lines.
Filanesib exhibits anti-proliferative against a broad range of human and rodent tumor cell lines, including a variety of leukemias and solid tumors, with EC₅₀s between 0.4 nM and 14.4 nM.
Filanesib (0.001-0.1 nM; 36 hours) induces apoptosis in a dose-dependent manner in HeLa cells.
Filanesib (3.13-6.25 nM; 44 hours) causes accumulation of cells in the G2/M phase of the cell cycle in a dose-dependent manner in HeLa cells.
Filanesib potently induces cell cycle block and subsequent death in leukemic cells via the mitochondrial pathway and has potential to eradicate AML progenitor cells.
Filanesib (3 μM; 6-24 hours) is able to induce caspase-2 activation.
Filanesib (0.003-3 μM; 24-48 hours) is cytotoxic in Type II EOC cells.

In Vivo: Filanesib (20 mg/kg, 30 mg/kg; i.p.; q4dx3) has anti-tumor activitiy in vivo.

相關(guān)產(chǎn)品：Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Cell Cycle/DNA Damage Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Cytoskeleton Compound Library  |  Anti-Blood Cancer Compound Library  |  Rare Diseases Drug Library  |  Pain-Related Compound Library  |  Highly Selective Inhibitors Library  |  Highly Selective Activators Library  |  Cell Death Library  |  MG-132  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  LY294002  |  Tamoxifen  |  Paclitaxel  |  Y-27632  |  Acetylcysteine  |  Angiotensin II human  |  2-Deoxy-D-glucose  |  Staurosporine  |  SB-431542  |  Actinomycin D  |  Deferoxamine mesylate  |  Bortezomib  |  5-Fluorouracil  |  Trametinib  |  Sorafenib  |  Oxaliplatin  |  Gemcitabine  |  Temozolomide  |  Rotenone  |  Mdivi-1  |  Elesclomol  |  Ruxolitinib  |  Decitabine  |  SP600125  |  MK-2206 dihydrochloride  |  Etoposide  |  Monomethyl auristatin E

熱門(mén)產(chǎn)品線：重組蛋白  |  化合物庫(kù)  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds